Company intelligence / Profile preview
AJ Vaccines
- Ownership
- Private
- Employees
- ~600
- Development stage
- Commercial
Overview
AJ Vaccines has several approved vaccines on the market, including inactivated polio vaccine, BCG for tuberculosis and bladder cancer immunotherapy, Td and TdaP. Their products are distributed globally with approvals in Denmark since at least the early 2000s. The company collaborates with WHO and UNICEF for global disease control efforts. Clinical trials include completed Phase IV studies.
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- Inactivated vaccines (e.g., polio)Live attenuated vaccines (e.g., BCG)Toxoid vaccines (e.g., Td, TdaP)Diagnostic solutionsTherapeutic solutions
- Industry
- Biotech
Drug pipeline
5 assets4 more assets in the full pipeline.
Request access →Partnerships
Beyond the preview
Go deeper on AJ Vaccines.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on AJ Vaccines.